Target intelligence / Profile preview

ADAM metallopeptidase domain 22 pseudogene

Molecular classification: Other, Pseudogene

Overview

The ADAM metallopeptidase domain 22 pseudogene (ENSG00000259769, also known as LOC646071) is a non-protein-coding pseudogene related to the functional gene ADAM22. While its parent gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family, involved in nervous system development and synaptic function, the pseudogene itself does not produce a functional protein and has no known direct biological or therapeutic relevance[3][5]. Pseudogenes like this are generally considered genomic relics without clinical or pharmacological significance.

Other names: LOC646071ENSG00000259769ADAM22 pseudogene

Beyond the preview

Go deeper on ADAM metallopeptidase domain 22 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADAM metallopeptidase domain 22 pseudogene.

Explore the full profile